New research suggests that individuals who come off blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who end conventional diet and exercise plans.
Published data in a major medical journal shows that while obese people often shed substantial amounts of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.
"Users buying such drugs must be informed of the danger of rapid weight regain when the therapy is stopped," warns researcher Dr. Susan Jebb.
That rate of regain suggests a reversion to starting weight in about a year and a half.
Analyzing Approaches
The research, which examined dozens of studies involving thousands of patients, compared the results of GLP-1 agonists with conventional dieting.
The team note that individuals who lose weight through diet and exercise generally have a more gradual weight regain—perhaps 100 grams monthly—once they finish.
The Reason for the Rapid Regain
Nutrition scientists suggest the mechanism of the drugs is key to understanding the accelerated weight return.
The injections copy a body's own chemical called GLP-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels far above than the body's typical production may cause the system to produce less of its endogenous hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement means hunger is unsuppressed, making binge eating far more likely."
A Lifelong Disease?
The NHS suggest the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.
A number of clinicians contend that, given the significant potential of weight regain, the treatment should be considered life-long.
This view is reinforced by drug manufacturers, who say that the findings "highlight the persistent nature of excess weight," akin to managing conditions like high blood pressure.
User Accounts
Users who have stopped the medication describe a powerful return of hunger.
"I experienced a switch that goes on and you're instantly extremely hungry," recalled an individual.
This challenge is compounded if patients have not adopted lasting lifestyle or habit changes during therapy.
Significant Interest
Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Use is more common among females compared to males.
- The middle-aged age group shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
Finally, researchers caution that while GLP-1 drugs are potent agents for weight loss, they are not a magic cure and long-term success likely depends on integrated lifestyle changes.
